Author details

Full Name

Miguel Reina-Campos

Affiliation

ORCID

Career Start Year

2014

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36960914	Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia report.	Ann N Y Acad Sci	2023
37648857	Metabolic programs of T cell tissue residency empower tumour immunity.	Nature	2023
38092754	Enhanced SREBP2-driven cholesterol biosynthesis by PKCÎ»/Î¹ deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis.	Nat Commun	2023
35545049	The lactate-NAD<sup>+</sup> axis activates cancer-associated fibroblasts by downregulating p62.	Cell Rep	2022
34544686	Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.	Cancer Immunol Res	2021
34037670	Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection.	J Exp Med	2021
33981085	CD8 T cell metabolism in infection and cancer.	Nature Reviews Immunology	2021
33207226	Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.	Developmental Cell	2021
32978300	Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population.	Proc Natl Acad Sci U S A	2020
31690618	The complexity of the serine glycine one-carbon pathway in cancer.	Journal of Cell Biology	2020
32105670	NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly.	Journal of Hepatology	2020
30827887	Increased Serine and One-Carbon Pathway Metabolism by PKCÎ»/Î¹ Deficiency Promotes Neuroendocrine Prostate Cancer.	Cancer Cell	2019
31844255	Antitumour T cells stand the test of time.	Nature	2019
31474570	The Dual Roles of the Atypical Protein Kinase Cs in Cancer.	Cancer Cell	2019
29634950	Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor.	Cancer Cell	2018
30552022	Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance.	Immunity	2018
29702207	Metabolic reprogramming of the tumor microenvironment by p62 and its partners.		2018
29694894	The Secretion of miR-200s by a PKCÎ¶/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer.	Cell Rep	2018
28988820	ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma.	Cell Metab	2017
28605656	Metabolism shapes the tumor microenvironment.	Current Opinion in Cell Biology	2017
27728806	p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.	Cancer Cell	2016
27089924	Nuclear fallout provides a new link between aPKC and polarized cell trafficking.	BMC Biology	2016
27211490	p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.	Cancer Cell	2016
27653691	Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCÎ»/Î¹.	Cell Rep	2016
26279575	Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade.	Cell Rep	2015
25660024	Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of Î²-Catenin and Yap by PKCÎ¶.	Cell Rep	2015
25002027	Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.	Cancer Cell	2014